The Association of the British Pharmaceutical Industry (ABPI) are in regular contact with both the pharmaceutical companies that supply medicines and the Government about any impact that the coronavirus could have on the supply of medicines to the NHS in the UK.

Pharmaceutical companies are not currently reporting any concerns about shortages of medicines or loss of manufacturing capacity as a result of COVID–19 restrictions.

There are robust procedures in place to manage the supply of medicines in the UK, and pharmaceutical companies will be taking all possible measures to secure supply for patients in line with Government guidance.

More information about the ABPI response to the coronavirus outbreak can be found here